<code id='D19248F817'></code><style id='D19248F817'></style>
    • <acronym id='D19248F817'></acronym>
      <center id='D19248F817'><center id='D19248F817'><tfoot id='D19248F817'></tfoot></center><abbr id='D19248F817'><dir id='D19248F817'><tfoot id='D19248F817'></tfoot><noframes id='D19248F817'>

    • <optgroup id='D19248F817'><strike id='D19248F817'><sup id='D19248F817'></sup></strike><code id='D19248F817'></code></optgroup>
        1. <b id='D19248F817'><label id='D19248F817'><select id='D19248F817'><dt id='D19248F817'><span id='D19248F817'></span></dt></select></label></b><u id='D19248F817'></u>
          <i id='D19248F817'><strike id='D19248F817'><tt id='D19248F817'><pre id='D19248F817'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:Wikipedia    Page View:9843
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In